EC
EcoR1 Capital Portfolio holdings
AUM
$1.69B
This Quarter Return
+9.38%
1 Year Return
+7.54%
3 Year Return
+113.08%
5 Year Return
+306.58%
10 Year Return
+4,328.75%
AUM
$746M
AUM Growth
+$746M
(+2.1%)
Cap. Flow
-$7.76M
Cap. Flow
% of AUM
-1.04%
Top 10 Holdings %
Top 10 Hldgs %
84.69%
Holding
50
New
8
Increased
8
Reduced
3
Closed
21
Top Buys
| 1 |
DRNA
Dicerna Pharmaceuticals, Inc.
DRNA
|
$35M |
| 2 |
Apellis Pharmaceuticals
APLS
|
$24.8M |
| 3 |
MacroGenics
MGNX
|
$21.7M |
| 4 |
ARRY
Array Biopharma Inc
ARRY
|
$20.9M |
| 5 |
Rhythm Pharmaceuticals
RYTM
|
$15.4M |
Top Sells
| 1 |
IMMU
Immunomedics Inc
IMMU
|
$40M |
| 2 |
MRNS
Marinus Pharmaceuticals, Inc
MRNS
|
$21.3M |
| 3 |
Forte Biosciences
FBRX
|
$18.7M |
| 4 |
CytomX Therapeutics
CTMX
|
$15.1M |
| 5 |
Indaptus Therapeutics
INDP
|
$13.4M |
Sector Composition
| 1 | Healthcare | 91.59% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Assembly Biosciences
ASMB
$190M
| $133M | 15% | 2,943,164 | – | – |
|
2
FibroGen
FGEN
$47.8M
| $97.1M | 10.93% | 2,047,737 +312,060 | +18% | +$14.8M |
|
3
Ironwood Pharmaceuticals
IRWD
$214M
| $88.2M | 9.93% | 5,885,583 +426,000 | +8% | +$6.39M |
|
4
Ascendis Pharma
ASND
$11.8B
| $84.4M | 9.51% | 2,107,600 | – | – |
|
5
Kura Oncology
KURA
$686M
| $57.6M | 6.49% | 3,766,852 | – | – |
|
|
DRNA
6
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $43.7M | 4.92% | 4,836,547 +3,878,555 | +405% | +$35M |
|
|
ARRY
7
DELISTED
Array Biopharma Inc
ARRY
| $36.9M | 4.15% | 2,882,712 +1,632,712 | +131% | +$20.9M |
|
8
Wave Life Sciences
WVE
$1.53B
| $32.9M | 3.7% | 936,163 +371,915 | +66% | +$13.1M |
|
|
MYOK
9
DELISTED
MyoKardia, Inc. Common Stock
MYOK
| $32.8M | 3.69% | 778,393 +88,407 | +13% | +$3.72M |
|
|
10
Apellis Pharmaceuticals
APLS
$3.48B
| $24.8M | 2.8% | +1,144,558 | New | +$24.8M |
|
|
11
MacroGenics
MGNX
$112M
| $21.7M | 2.44% | +1,140,794 | New | +$21.7M |
|
|
12
Rhythm Pharmaceuticals
RYTM
$6.85B
| $15.4M | 1.73% | +530,161 | New | +$15.4M |
|
|
IMDZ
13
DELISTED
Immune Design Corp.
IMDZ
| $13.9M | 1.56% | +3,562,600 | New | +$13.9M |
|
|
ATYR
14
aTyr Pharma
ATYR
$527M
| $13.7M | 1.54% | 3,917,972 -16,877 | -0.4% | -$59.1K |
|
15
Galapagos
GLPG
$2.07B
| $10.4M | 1.17% | 110,384 -130,392 | -54% | -$12.2M |
|
|
ONC
16
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $8.18M | 0.92% | 83,667 +73,867 | +754% | +$7.22M |
|
17
Corvus Pharmaceuticals
CRVS
$428M
| $6.1M | 0.69% | 588,432 -320,093 | -35% | -$3.32M |
|
|
ACHN
18
DELISTED
Achillion Pharmaceuticals, Inc.
ACHN
| $5.3M | 0.6% | +1,840,725 | New | +$5.3M |
|
|
KIN
19
DELISTED
Kindred Biosciences, Inc.
KIN
| $5.15M | 0.58% | 544,880 | – | – |
|
|
CMTA
20
DELISTED
Clementia Pharmaceuticals Inc.
CMTA
| $3.69M | 0.41% | 194,166 | – | – |
|
21
Madrigal Pharmaceuticals
MDGL
$9.76B
| $3.21M | 0.36% | +35,000 | New | +$3.21M |
|
22
Denali Therapeutics
DNLI
$2.23B
| $3.13M | 0.35% | +200,000 | New | +$3.13M |
|
23
Xencor
XNCR
$580M
| $2.48M | 0.28% | 112,976 +22,862 | +25% | +$501K |
|
|
MRTX
24
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $1.88M | 0.21% | +103,240 | New | +$1.88M |
|
25
Aclaris Therapeutics
ACRS
$209M
| – | – | -60,000 | Closed | -$1.55M |
|